Current Treatment for Venom-Induced Consumption Coagulopathy Resulting from Snakebite

PLoS Neglected Tropical Diseases

Volumn 8, Issue 10, 2014, Pages

  Maduwage, Kalana ^a,b,c   Isbister, Geoffrey K ^a,b,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b South Asian Clinical Toxicology Research Collaboration   (Sri Lanka)

^c UNIVERSITY OF PERADENIYA   (Sri Lanka)

^d CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEHRINGWERKE ANTIVENOM; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; ECHI TAB G OVINE ANTIVENOM; EQUINE ANTIVENOM; FIBRINOGEN; FRESH FROZEN PLASMA; HEPARIN; IMMUNOGLOBULIN; POLONGA TAB; PROTHROMBIN; SAIMR ANTIVENOM; SNAKE VENOM ANTISERUM; UNCLASSIFIED DRUG; SNAKE VENOM; VENOM ANTISERUM;

ANAPHYLAXIS; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; CONTROLLED CLINICAL TRIAL (TOPIC); DISSEMINATED INTRAVASCULAR CLOTTING; DRUG EFFICACY; DRUG TREATMENT FAILURE; ECHIS (SNAKE); HUMAN; INTERNATIONAL NORMALIZED RATIO; MORTALITY; NONHUMAN; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RANDOMIZED CONTROLLED TRIAL (TOPIC); SNAKEBITE; TRANSFUSION RELATED ACUTE LUNG INJURY; VENOM INDUCED CONSUMPTION COAGULOPATHY; ANIMAL; COMPLICATION; DISSEMINATED INTRAVASCULAR COAGULATION; PLASMA;

ANIMALS; ANTIVENINS; DISSEMINATED INTRAVASCULAR COAGULATION; HEPARIN; HUMANS; PLASMA; SNAKE BITES; SNAKE VENOMS;

EID: 84920531793     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003220     Document Type: Article

References (119)

1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, et al. (2008) The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med 5: e218.
2. Isbister GK, (2010) Snakebite doesn't cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming. Semin Thromb Hemost 36: 444–451.
3. Isbister GK, Scorgie FE, O'Leary MA, Seldon M, Brown SG, et al. (2010) Factor deficiencies in venom-induced consumption coagulopathy resulting from Australian elapid envenomation: Australian Snakebite Project (ASP-10). J Thromb Haemost 8: 2504–2513.
4. Isbister GK, (2009) Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy. Semin Thromb Hemost 35: 93–103.
5. Aitchison JM, (1990) Boomslang bite–diagnosis and management. A report of 2 cases. S Afr Med J 78: 39–42.
6. Lu Q, Clemetson JM, Clemetson KJ, (2005) Snake venoms and hemostasis. J Thromb Haemost 3: 1791–1799.
7. Phillips RE, Theakston RD, Warrell DA, Galigedara Y, Abeysekera DT, et al. (1988) Paralysis, rhabdomyolysis and haemolysis caused by bites of Russell's viper (Vipera russelli pulchella) in Sri Lanka: failure of Indian (Haffkine) antivenom. Q J Med 68: 691–715.
8. Warrell DA, Davidson N, Greenwood BM, Ormerod LD, Pope HM, et al. (1977) Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med 46: 33–62.
9. Isbister GK, Duffull SB, Brown SG, (2009) Failure of antivenom to improve recovery in Australian snakebite coagulopathy. QJM 102: 563–568.
10. Kularatne SA, Budagoda BD, Gawarammana IB, Kularatne WK, (2009) Epidemiology, clinical profile and management issues of cobra (Naja naja) bites in Sri Lanka: first authenticated case series. Trans R Soc Trop Med Hyg 103: 924–930.
11. Kularatne SA, Sivansuthan S, Medagedara SC, Maduwage K, de Silva A, (2011) Revisiting saw-scaled viper (Echis carinatus) bites in the Jaffna Peninsula of Sri Lanka: distribution, epidemiology and clinical manifestations. Trans R Soc Trop Med Hyg 105: 591–597.
12. Maduwage K, Kularatne K, Wazil A, Gawarammana I, (2011) Coagulopthy, acute kidney injury and death following Hypnale zara envenoming: the first case report from Sri Lanka. Toxicon 58: 641–643.
13. Maduwage K, Scorgie FE, Silva A, Shahmy S, Mohamed F, et al. (2013) Hump-nosed pit viper (Hypnale hypnale) envenoming causes mild coagulopathy with incomplete clotting factor consumption. Clin Toxicol (Phila) 51: 527–531.
14. Ariaratnam CA, Thuraisingam V, Kularatne SA, Sheriff MH, Theakston RD, et al. (2008) Frequent and potentially fatal envenoming by hump-nosed pit vipers (Hypnale hypnale and H. nepa) in Sri Lanka: lack of effective antivenom. Trans R Soc Trop Med Hyg 102: 1120–1126.
15. Sano-Martins IS, Fan HW, Castro SC, Tomy SC, Franca FO, et al. (1994) Reliability of the simple 20 minute whole blood clotting test (WBCT20) as an indicator of low plasma fibrinogen concentration in patients envenomed by Bothrops snakes. Butantan Institute Antivenom Study Group. Toxicon 32: 1045–1050.
16. Isbister GK, Maduwage K, Shahmy S, Mohamed F, Abeysinghe C, et al. (2013) Diagnostic 20-min whole blood clotting test in Russell's viper envenoming delays antivenom administration. QJM 106: 925–932.
17. Daudu I, Theakston RD, (1988) Preliminary trial of a new polyspecific antivenom in Nigeria. Ann Trop Med Parasitol 82: 311–313.
18. Chippaux JP, Lang J, Eddine SA, Fagot P, Rage V, et al. (1998) Clinical safety of a polyvalent F(ab′)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l'Ouest) Investigators. Trans R Soc Trop Med Hyg 92: 657–662.
19. Chippaux JP, Lang J, Amadi-Eddine S, Fagot P, Le Mener V, (1999) Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon. Am J Trop Med Hyg 61: 1017–1018.
20. Bregani E, Cantoni F, Tantardini F, (2006) Snake bites in South Chad. Comparision between three different polyvalent anti-snake venom immunotherapies. Giornale Italiano Di Medicina Tropicale 11: 25–28.
21. Brown SG, Caruso N, Borland ML, McCoubrie DL, Celenza A, et al. (2009) Clotting factor replacement and recovery from snake venom-induced consumptive coagulopathy. Intensive Care Med 35: 1532–1538.
22. Mion G, Larreche S, Benois A, Petitjeans F, Puidupin M, (2013) Hemostasis dynamics during coagulopathy resulting from Echis envenomation. Toxicon 76: 103–109.
23. Sotelo N, (2008) Review of treatment and complications in 79 children with rattlesnake bite. Clin Pediatr (Phila) 47: 483–489.
24. Warrell DA, Pope HM, Prentice CR, (1976) Disseminated intravascular coagulation caused by the carpet viper (Echis carinatus): trial of heparin. Br J Haematol 33: 335–342.
25. Kamiguti AS, Rugman FP, Theakston RD, Franca FO, Ishii H, et al. (1992) The role of venom haemorrhagin in spontaneous bleeding in Bothrops jararaca envenoming. Butantan Institute Antivenom Study Group. Thromb Haemost 67: 484–488.
26. Antonypillai CN, Wass JA, Warrell DA, Rajaratnam HN, (2011) Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management. QJM 104: 97–108.
27. Jeevagan V, Katulanda P, Gnanathasan CA, Warrell DA, (2013) Acute pituitary insufficiency and hypokalaemia following envenoming by Russell's viper (Daboia russelii) in Sri Lanka: Exploring the pathophysiological mechanisms. Toxicon 63: 78–82.
28. Offerman SR, Barry JD, Schneir A, Clark RF, (2003) Biphasic rattlesnake venom-induced thrombocytopenia. J Emerg Med 24: 289–293.
29. Odeleye AA, Presley AE, Passwater ME, Mintz PD, (2004) Report of two cases: Rattlesnake venom-induced thrombocytopenia. Ann Clin Lab Sci 34: 467–470.
30. Johnston CI, Brown SG, O'Leary MA, Currie BJ, Greenberg R, et al. (2013) Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19). Clin Toxicol (Phila) 51: 417–424.
31. Warrell DA, editor (1992) The global problem of snake bite: its prevention and treatments. Singapore: National University of Singapore.
32. Gutierrez JM, Leon G, Lomonte B, (2003) Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation. Clin Pharmacokinet 42: 721–741.
33. Theakston RD, Warrell DA, (1991) Antivenoms: a list of hyperimmune sera currently available for the treatment of envenoming by bites and stings. Toxicon 29: 1419–1470.
34. Heard K, O'Malley GF, Dart RC, (1999) Antivenom therapy in the Americas. Drugs 58: 5–15.
35. Isbister GK, (2010) Antivenom efficacy or effectiveness: the Australian experience. Toxicology 268: 148–154.
36. Riviere G, Choumet V, Audebert F, Sabouraud A, Debray M, et al. (1997) Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. J Pharmacol Exp Ther 281: 1–8.
37. Pepin-Covatta S, Lutsch C, Grandgeorge M, Lang J, Scherrmann JM, (1996) Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab′)2-scorpion venom interactions. Toxicol Appl Pharmacol 141: 272–277.
38. Pepin-Covatta S, Lutsch C, Lang J, Scherrmann JM, (1998) Preclinical assessment of immunoreactivity of a new purified equine F(ab′)2 against European viper venom. J Pharm Sci 87: 221–225.
39. Isbister GK, Woods D, Alley S, O'Leary MA, Seldon M, et al. (2010) Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom. Toxicon 56: 75–85.
40. Isbister GK, O'Leary MA, Schneider JJ, Brown SG, Currie BJ, (2007) Efficacy of antivenom against the procoagulant effect of Australian brown snake (Pseudonaja sp.) venom: in vivo and in vitro studies. Toxicon 49: 57–67.
41. Ramos-Cerrillo B, de Roodt AR, Chippaux JP, Olguin L, Casasola A, et al. (2008) Characterization of a new polyvalent antivenom (Antivipmyn Africa) against African vipers and elapids. Toxicon 52: 881–888.
42. Segura A, Villalta M, Herrera M, Leon G, Harrison R, et al. (2010) Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa. Toxicon 55: 369–374.
43. Bogarin G, Morais JF, Yamaguchi IK, Stephano MA, Marcelino JR, et al. (2000) Neutralization of crotaline snake venoms from Central and South America by antivenoms produced in Brazil and Costa Rica. Toxicon 38: 1429–1441.
44. Tanos PP, Isbister GK, Lalloo DG, Kirkpatrick CM, Duffull SB, (2008) A model for venom-induced consumptive coagulopathy in snake bite. Toxicon 52: 769–780.
45. Gulati A, Isbister GK, Duffull SB, (2013) Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17). Toxicon 61: 94–104.
46. Wajima T, Isbister GK, Duffull SB, (2009) A comprehensive model for the humoral coagulation network in humans. Clin Pharmacol Ther 86: 290–298.
47. Stone SF, Isbister GK, Shahmy S, Mohamed F, Abeysinghe C, et al. (2013) Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation. PLoS Negl Trop Dis 7: e2326.
48. Abubakar IS, Abubakar SB, Habib AG, Nasidi A, Durfa N, et al. (2010) Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria. PLoS Negl Trop Dis 4: e767.
49. Ariaratnam CA, Sjostrom L, Raziek Z, Kularatne SA, Arachchi RW, et al. (2001) An open, randomized comparative trial of two antivenoms for the treatment of envenoming by Sri Lankan Russell's viper (Daboia russelii russelii). Trans R Soc Trop Med Hyg 95: 74–80.
50. Cardoso JL, Fan HW, Franca FO, Jorge MT, Leite RP, et al. (1993) Randomized comparative trial of three antivenoms in the treatment of envenoming by lance-headed vipers (Bothrops jararaca) in Sao Paulo, Brazil. Q J Med 86: 315–325.
51. Dart RC, Seifert SA, Boyer LV, Clark RF, Hall E, et al. (2001) A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med 161: 2030–2036.
52. Meyer WP, Habib AG, Onayade AA, Yakubu A, Smith DC, et al. (1997) First clinical experiences with a new ovine Fab Echis ocellatus snake bite antivenom in Nigeria: randomized comparative trial with Institute Pasteur Serum (Ipser) Africa antivenom. Am J Trop Med Hyg 56: 291–300.
53. Myint L, Tin Nu S, Myint Aye M, Than T, Thein T, et al. (1989) Heparin therapy in Russell's viper bite victims with impending dic (a controlled trial). Southeast Asian J Trop Med Public Health 20: 271–277.
54. Karnchanachetanee C, Hanvivatvong O, Mahasandana S, (1994) Monospecific antivenin therapy in Russell's viper bite. J Med Assoc Thai 77: 293–297.
55. Otero R, Gutierrez JM, Nunez V, Robles A, Estrada R, et al. (1996) A randomized double-blind clinical trial of two antivenoms in patients bitten by Bothrops atrox in Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Trans R Soc Trop Med Hyg 90: 696–700.
56. Otero-Patino R, Cardoso JL, Higashi HG, Nunez V, Diaz A, et al. (1998) A randomized, blinded, comparative trial of one pepsin-digested and two whole IgG antivenoms for Bothrops snake bites in Uraba, Colombia. The Regional Group on Antivenom Therapy Research (REGATHER). Am J Trop Med Hyg 58: 183–189.
57. Otero R, Gutierrez JM, Rojas G, Nunez V, Diaz A, et al. (1999) A randomized blinded clinical trial of two antivenoms, prepared by caprylic acid or ammonium sulphate fractionation of IgG, in Bothrops and Porthidium snake bites in Colombia: correlation between safety and biochemical characteristics of antivenoms. Toxicon 37: 895–908.
58. Otero R, Leon G, Gutierrez JM, Rojas G, Toro MF, et al. (2006) Efficacy and safety of two whole IgG polyvalent antivenoms, refined by caprylic acid fractionation with or without beta-propiolactone, in the treatment of Bothrops asper bites in Colombia. Trans R Soc Trop Med Hyg 100: 1173–1182.
59. Otero-Patino R, Segura A, Herrera M, Angulo Y, Leon G, et al. (2012) Comparative study of the efficacy and safety of two polyvalent, caprylic acid fractionated [IgG and F(ab′)2] antivenoms, in Bothrops asper bites in Colombia. Toxicon 59: 344–355.
60. Pardal PP, Souza SM, Monteiro MR, Fan HW, Cardoso JL, et al. (2004) Clinical trial of two antivenoms for the treatment of Bothrops and Lachesis bites in the north eastern Amazon region of Brazil. Trans R Soc Trop Med Hyg 98: 28–42.
61. Paul V, Prahlad KA, Earali J, Francis S, Lewis F, (2003) Trial of heparin in viper bites. J Assoc Physicians India 51: 163–166.
62. Paul V, Pratibha S, Prahlad KA, Earali J, Francis S, et al. (2004) High-dose anti-snake venom versus low-dose anti-snake venom in the treatment of poisonous snake bites–a critical study. J Assoc Physicians India 52: 14–17.
63. Paul V, Pudoor A, Earali J, John B, Anil Kumar CS, et al. (2007) Trial of low molecular weight heparin in the treatment of viper bites. J Assoc Physicians India 55: 338–342.
64. Sellahewa KH, Kumararatne MP, Dassanayake PB, Wijesundera A, (1994) Intravenous immunoglobulin in the treatment of snake bite envenoming: a pilot study. Ceylon Med J 39: 173–175.
65. Shah PK, Chittora MD, Shekhawat JS, Khangaroot D, Vyas MM, (1986) Role of heparin in the management of snake (Echis carinatus) bite cases. J Assoc Physicians India 34: 621–623.
66. Smalligan R, Cole J, Brito N, Laing GD, Mertz BL, et al. (2004) Crotaline snake bite in the Ecuadorian Amazon: randomised double blind comparative trial of three South American polyspecific antivenoms. BMJ 329: 1129.
67. Thomas PP, Jacob J, (1985) Randomised trial of antivenom in snake envenomation with prolonged clotting time. Br Med J (Clin Res Ed) 291: 177–178.
68. Warrell DA, Davidson NM, Omerod LD, Pope HM, Watkins BJ, et al. (1974) Bites by the saw-scaled or carpet viper (Echis carinatus): trial of two specific antivenoms. Br Med J 4: 437–440.
69. Warrell DA, Warrell MJ, Edgar W, Prentice CR, Mathison J, (1980) Comparison of Pasteur and Behringwerke antivenoms in envenoming by the carpet viper (Echis carinatus). Br Med J 280: 607–609.
70. Warrell DA, Looareesuwan S, Theakston RD, Phillips RE, Chanthavanich P, et al. (1986) Randomized comparative trial of three monospecific antivenoms for bites by the Malayan pit viper (Calloselasma rhodostoma) in southern Thailand: clinical and laboratory correlations. Am J Trop Med Hyg 35: 1235–1247.
71. Jorge MT, Cardoso JL, Castro SC, Ribeiro L, Franca FO, et al. (1995) A randomized ‘blinded’ comparison of two doses of antivenom in the treatment of Bothrops envenoming in Sao Paulo, Brazil. Trans R Soc Trop Med Hyg 89: 111–114.
72. Abubakar SB, Abubakar IS, Habib AG, Nasidi A, Durfa N, et al. (2010) Pre-clinical and preliminary dose-finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria. Toxicon 55: 719–723.
73. Mann G, (1978) Echis colorata bites in Israel: an evaluation of specific antiserum use on the base of 21 cases of snake bite. Toxicol Eur Res 1: 365–369.
74. Suchithra N, Pappachan JM, Sujathan P, (2008) Snakebite envenoming in Kerala, South India: clinical profile and factors involved in adverse outcomes. Emerg Med J 25: 200–204.
75. Trevett AJ, Lalloo DG, Nwokolo NC, Naraqi S, Kevau IH, et al. (1995) The efficacy of antivenom in the treatment of bites by the Papuan taipan (Oxyuranus scutellatus canni). Trans R Soc Trop Med Hyg 89: 322–325.
76. Visser LE, Kyei-Faried S, Belcher DW, Geelhoed DW, van Leeuwen JS, et al. (2008) Failure of a new antivenom to treat Echis ocellatus snake bite in rural Ghana: the importance of quality surveillance. Trans R Soc Trop Med Hyg 102: 445–450.
77. Win A, Tin T, Khin Maung M, Aye K, Hla P, et al. (1996) Clinical trial of intramuscular anti-snake venom administration as a first aid measure in the field in the management of Russell's viper bite patients. Southeast Asian J Trop Med Public Health 27: 494–497.
78. Tin Na S, Myint L, Khin Ei H, Tin T, Tun P, (1992) Heparin therapy in Russell's viper bite victims with disseminated intravascular coagulation: a controlled trial. Southeast Asian J Trop Med Public Health 23: 282–287.
79. Srimannarayana J, Dutta TK, Sahai A, Badrinath S, (2004) Rational use of anti-snake venom (ASV): trial of various regimens in hemotoxic snake envenomation. J Assoc Physicians India 52: 788–793.
80. Churchman A, O'Leary MA, Buckley NA, Page CB, Tankel A, et al. (2010) Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11). Med J Aust 193: 696–700.
81. Allen GE, Brown SG, Buckley NA, O'Leary MA, Page CB, et al. (2012) Clinical effects and antivenom dosing in brown snake (Pseudonaja spp.) envenoming–Australian snakebite project (ASP-14). PLoS ONE 7: e53188.
82. Isbister GK, O'Leary M, Miller M, Brown SG, Ramasamy S, et al. (2008) A comparison of serum antivenom concentrations after intravenous and intramuscular administration of redback (widow) spider antivenom. Br J Clin Pharmacol 65: 139–143.
83. Hung DZ, Yu YJ, Hsu CL, Lin TJ, (2006) Antivenom treatment and renal dysfunction in Russell's viper snakebite in Taiwan: a case series. Trans R Soc Trop Med Hyg 100: 489–494.
84. Jelinek GA, Smith A, Lynch D, Celenza A, Irving I, et al. (2005) The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care 33: 36–40.
85. Tibballs J, (2005) Fresh frozen plasma after brown snake bite–helpful or harmful? Anaesth Intensive Care 33: 13–15.
86. Isbister GK, Buckley NA, Page CB, Scorgie FE, Lincz LF, et al. (2013) A randomized controlled trial of fresh frozen plasma for treating venom-induced consumption coagulopathy in cases of Australian snakebite (ASP-18). J Thromb Haemost 11: 1310–1318.
87. Pandey S, Vyas GN, (2012) Adverse effects of plasma transfusion. Transfusion 52 Suppl 1: 65S–79S.
88. Than T, Hutton RA, Myint L, Khin Ei H, Soe S, et al. (1988) Haemostatic disturbances in patients bitten by Russell's viper (Vipera russelli siamensis) in Burma. Br J Haematol 69: 513–520.
89. Kulapongs P, Boocharngkul S, Tostiarat T, (1975) The defibrination syndrome in Malayan pit viper (Agkistrodon rhodostoma). Chiang Mai Medical Bulletin 14: 20.
90. Hutton RA, Looareesuwan S, Ho M, Silamut K, Chanthavanich P, et al. (1990) Arboreal green pit vipers (genus Trimeresurus) of South-East Asia: bites by T. albolabris and T. macrops in Thailand and a review of the literature. Trans R Soc Trop Med Hyg 84: 866–874.
91. Rojnuckarin P, Intragumtornchai T, Sattapiboon R, Muanpasitporn C, Pakmanee N, et al. (1999) The effects of green pit viper (Trimeresurus albolabris and Trimeresurus macrops) venom on the fibrinolytic system in human. Toxicon 37: 743–755.
92. Li QB, Huang GW, Kinjoh K, Nakamura M, Kosugi T, (2001) Hematological studies on DIC-like findings observed in patients with snakebite in south China. Toxicon 39: 943–948.
93. Mori K, Hisa S, Suzuki S, Sugai K, Sakai H, et al. (1983) [A case of severe defibrination syndrome due to snake (Rhabdophis tigrinus) bite]. Rinsho Ketsueki 24: 256–262.
94. Lalloo DG, Trevett AJ, Owens D, Minei J, Naraqi S, et al. (1995) Coagulopathy following bites by the Papuan taipan (Oxyuranus scutellatus canni). Blood Coagulation & Fibrinolysis 6: 65–72.
95. Barrantes A, Solis V, Bolanos R, (1985) [Alterations in the coagulation mechanisms of patients bitten by Bothrops asper (Terciopelo)]. Toxicon 23: 399–407.
96. Kamiguti AS, Matsunaga S, Spir M, Sano-Martins IS, Nahas L, (1986) Alterations of the blood coagulation system after accidental human inoculation by Bothrops jararaca venom. Braz J Med Biol Res 19: 199–204.
97. Sano-Martins IS, Tomy SC, Campolina D, Dias MB, de Castro SC, et al. (2001) Coagulopathy following lethal and non-lethal envenoming of humans by the South American rattlesnake (Crotalus durissus) in Brazil. QJM 94: 551–559.
98. Kamiguti AS, Cardoso JL, (1989) Haemostatic changes caused by the venoms of South American snakes. Toxicon 27: 955–963.
99. Budzynski AZ, Pandya BV, Rubin RN, Brizuela BS, Soszka T, et al. (1984) Fibrinogenolytic afibrinogenemia after envenomation by western diamondback rattlesnake (Crotalus atrox). Blood 63: 1–14.
100. Kitchens C, Eskin T, (2008) Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome. J Med Toxicol 4: 180–183.
101. Hardy DL, Jeter M, Corrigan JJ, Jr (1982) Envenomation by the northern blacktail rattlesnake (Crotalus molossus molossus): report of two cases and the in vitro effects of the venom on fibrinolysis and platelet aggregation. Toxicon 20: 487–493.
102. Hasiba U, Rosenbach LM, Rockwell D, Lewis JH, (1975) DiC-like syndrome after envenomation by the snake, Crotalus horridus horridus. N Engl J Med 292: 505–507.
103. Bush SP, Green SM, Moynihan JA, Hayes WK, Cardwell MD, (2002) Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med 40: 619–624.
104. Boels D, Hamel JF, Bretaudeau Deguigne M, Harry P, (2012) European viper envenomings: Assessment of Viperfav and other symptomatic treatments. Clin Toxicol (Phila) 50: 189–196.
105. Petite J, (2005) Viper bites: treat or ignore? Review of a series of 99 patients bitten by Vipera aspis in an alpine Swiss area. Swiss Med Wkly 135: 618–625.
106. Luksic B, Culic V, Stricevic L, Brizic I, Poljak NK, et al. (2010) Infant death after nose-horned viper (Vipera ammodytes ammodytes) bite in Croatia: A case report. Toxicon 56: 1506–1509.
107. Mebs D, Holada K, Kornalik F, Simak J, Vankova H, et al. (1998) Severe coagulopathy after a bite of a green bush viper (Atheris squamiger): case report and biochemical analysis of the venom. Toxicon 36: 1333–1340.
108. Top LJ, Tulleken JE, Ligtenberg JJ, Meertens JH, van der Werf TS, et al. (2006) Serious envenomation after a snakebite by a Western bush viper (Atheris chlorechis) in the Netherlands: a case report. Neth J Med 64: 153–156.
109. Hatten BW, Bueso A, French LK, Hendrickson RG, Horowitz BZ, (2013) Envenomation by the Great Lakes Bush Viper (Atheris nitschei). Clin Toxicol (Phila) 51: 114–116.
110. Lifshitz M, Kastel H, Harman-Boehm I, (2002) Cerastes cerastes envenomation in an 18 year old female: a case report. Toxicon 40: 1227–1229.
111. Schneemann M, Cathomas R, Laidlaw ST, El Nahas AM, Theakston RD, et al. (2004) Life-threatening envenoming by the Saharan horned viper (Cerastes cerastes) causing micro-angiopathic haemolysis, coagulopathy and acute renal failure: clinical cases and review. QJM 97: 717–727.
112. Lifshitz M, Kapelushnik J, Ben-Harosh M, Sofer S, (2000) Disseminated intravascular coagulation after cerastes vipera envenomation in a 3-year-old child: a case report. Toxicon 38: 1593–1598.
113. Valenta J, Stach Z, Fricova D, Zak J, Balik M, (2008) Envenoming by the viperid snake Proatheris superciliaris: a case report. Toxicon 52: 392–394.
114. Jennings BR, Spearman CW, Kirsch RE, Shephard EG, (1999) A novel high molecular weight fibrinogenase from the venom of Bitis arietans. Biochim Biophys Acta 1427: 82–91.
115. Warrell DA, Ormerod LD, Davidson NM, (1975) Bites by puff-adder (Bitis arietans) in Nigeria, and value of antivenom. Br Med J 4: 697–700.
116. Lavonas EJ, Tomaszewski CA, Ford MD, Rouse AM, Kerns WP, 2nd (2002) Severe puff adder (Bitis arietans) envenomation with coagulopathy. J Toxicol Clin Toxicol 40: 911–918.
117. McNally T, Conway GS, Jackson L, Theakston RD, Marsh NA, et al. (1993) Accidental envenoming by a Gaboon viper (Bitis gabonica): the haemostatic disturbances observed and investigation of in vitro haemostatic properties of whole venom. Trans R Soc Trop Med Hyg 87: 66–70.
118. Porath A, Gilon D, Schulchynska-Castel H, Shalev O, Keynan A, et al. (1992) Risk indicators after envenomation in humans by Echis coloratus (mid-east saw scaled viper). Toxicon 30: 25–32.
119. Gillissen A, Theakston RD, Barth J, May B, Krieg M, et al. (1994) Neurotoxicity, haemostatic disturbances and haemolytic anaemia after a bite by a Tunisian saw-scaled or carpet viper (Echis ‘pyramidum’-complex): failure of antivenom treatment. Toxicon 32: 937–944.